Keywords: Pharma outlook, Zacks Equity Research, M&A activity, Licensing

Zacks analysts view pharma industry outlook

Article | 04 March 2011

The pharmaceutical industry continues to witness major challenges like sluggish prescription trends, European Union pricing pressure, intensifying generic competition, pipeline ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in